Trials / Completed
CompletedNCT02815839
Single Dose Study of SHR4640 in Healthy Subjects
A Phase 1, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Safety, Tolerability, Food Effect, Pharmacokinetics, and Pharmacodynamics of Single Doses of SHR4640 in Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The objective of the study is to assess the safety, tolerance, food effect, pharmacokinetic and pharmacodynamic properties of single dose adminstration of SHR4640 in healthy volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SHR4640 | |
| DRUG | Placebo |
Timeline
- Start date
- 2015-11-01
- Primary completion
- 2017-02-01
- Completion
- 2017-02-01
- First posted
- 2016-06-28
- Last updated
- 2017-02-28
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02815839. Inclusion in this directory is not an endorsement.